Protease Inhibitors Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
- Transparency Market Research
The ‘protease inhibitor’ are molecules which have many different applications. In some cases, the ‘protease inhibitor’ (PI) indicates a type of drug that is primarily used to treat hepatitis and HIV/AIDS. Proteases are enzymes that cleave or cut proteins. Protease inhibitor inhibits the function of protease, thereby preventing the viral replication. Inhibitors also block the proteolytic cleavage of the precursor protein required for the production of new virus particles. These protease inhibitor drugs, apart from antiviral drugs, can be used in the treatment of cancer and diabetes. Several protease inhibitors can be used as reagents in protein purification or cell/tissue extraction.
The global protease inhibitors market is expected to expand at a significant pace during the forecast period. Development of pharmaceutical protease inhibitor is of great interest which target the specific protease enzyme (for example, in HIV anti-retroviral drugs). Thus, increasing prevalence of viral diseases such as HIV/AIDS and hepatitis C is expected to drive the market during the forecast period. The rising awareness about anti-retroviral therapy and cancer treatment is another major factor contributing to growth of the global protease inhibitors market. Extensive research and development activities in the field of protein purification, pharmacology, animal tissue culture, and molecular biology are expected to drive the global market by 2025. Moreover, surge in the number of pharmaceutical companies, rise in the prevalence of lifestyle diseases, and approval of PI drugs are likely to propel the market during the forecast period. Lack of awareness about PI drugs in developing countries and high cost of protease inhibitor reagents are some of the factors that may restrain the global protease inhibitors market during the forecast period.
The global protease inhibitors market can be segmented based on mechanism of action, application, end-user, and region. Based on mechanism of action, the global market can be divided into serine protease inhibitors, cysteine protease inhibitors, amino peptidase inhibitor, aspartic protease inhibitors, metalloprotease inhibitors, and others. Based on application, the global protease inhibitors market has been divided into commodity protease inhibitor, research tool protease inhibitor, and protease inhibitor drugs. The protease inhibitor drugs segment is expected hold a significant share of the global market from 2017 to 2025, due to high prevalence of anti-retroviral diseases across the world. Based on end-user, the global market has been divided into hospitals & diagnostic centers, pharmaceutical industries, and academic & research institutes.
Geographically, the global protease inhibitors market can be fragmented into North America, Latin America, Europe, Middle East & Africa, and Asia Pacific. North America is anticipated to dominate the global protease inhibitors market, during the forecast period, followed by Europe. Factors such as high prevalence of HIV and chronic HCV in the region, growing industrial sector, and advanced health care infrastructure are anticipated to drive the market in North America during the forecast period. Furthermore, in order to strengthen their position in an established market, prominent players are focusing on the region. The market in Asia Pacific is expected to register the maximum growth rate during the forecast period, due to factors such as rising health care expenditure, increasing geriatric population, surging disposable income, high prevalence of chronic diseases, growing focus of global pharmaceutical companies on Asia Pacific, and increasing research activities. Furthermore, rise in awareness about anti-retroviral therapy in regions such as Asia and Africa is driving the global protease inhibitors market.
In order to attain a competitive position in the global market, key players in the protease inhibitors market are engaged in mergers and acquisitions, extensive R&D activities, launch of cost-effective and efficient vaccine products, and collaborative partnerships. Some of the prominent players operating in the global protease inhibitors market are Thermo Fisher Scientific Inc., Sigma-Aldrich, Inc., CYTOSKELETON, INC., Merck & Co., Inc., Genentech, Inc., and Boehringer Ingelheim International GmbH.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Pharmaceutical
PharmaceuticalChinese Markets for Mental Illness Drugs
PharmaceuticalChinese Markets for Anti-Dermatomycosis Skin Drugs
PharmaceuticalChinese Markets for Incretion Drugs
PharmaceuticalChinese Markets for Hypertension Drugs
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017